We are live on ! Find out more
TC

Tejara Capital Portfolio holdings

AUM $303M
1-Year Est. Return 5.43%
This Fund
S&P 500
This Quarter Est. Return
+7.71%
1 Year Est. Return
+5.43%
3 Year Est. Return
+13.91%
5 Year Est. Return
10 Year Est. Return
AUM
$239M
AUM Growth
+$62.3M
Cap. Flow
+$47.1M
Cap. Flow %
19.71%
Top 10 Hldgs %
47.13%
Holding
79
New
15
Increased
27
Reduced
17
Closed
12

Sector Composition

Rank Sector Weight
1 Healthcare 38.1%
2 Energy 31.79%
3 Materials 9.33%
4 Financials 6.54%
5 Communication Services 3.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRO icon
51
Frontline
FRO
$8.71B
$818K 0.34%
+40,800
New +$843K
DOLE icon
52
Dole
DOLE
$1.38B
$651K 0.27%
+52,964
New +$612K
TRMD icon
53
TORM
TRMD
$3.05B
$608K 0.25%
20,000
-10,000
-33% -$295K
CMRX
54
DELISTED
Chimerix, Inc.
CMRX
$529K 0.22%
550,076
+177,436
+48% +$172K
ABUS icon
55
Arbutus Biopharma
ABUS
$847M
$450K 0.19%
180,077
CCJ icon
56
Cameco
CCJ
$36.8B
$431K 0.18%
10,000
-175,651
-95% -$7.35M
ATAI icon
57
AtaiBeckley Inc
ATAI
$2.66B
$409K 0.17%
290,215
SPRY icon
58
ARS Pharmaceuticals
SPRY
$579M
$404K 0.17%
73,739
-30,000
-29% -$131K
CRK icon
59
Comstock Resources
CRK
$3.7B
$360K 0.15%
+40,700
New +$440K
MAGN
60
Magnera Corp
MAGN
$493M
$335K 0.14%
13,272
-5,205
-28% -$110K
VINC
61
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$275K 0.12%
11,667
DTIL icon
62
Precision BioSciences
DTIL
$178M
$271K 0.11%
24,767
+11,480
+86% +$124K
OVID icon
63
Ovid Therapeutics
OVID
$427M
$236K 0.1%
+73,153
New +$250K
RNLX
64
DELISTED
Renalytix plc American Depositary Shares
RNLX
$156K 0.07%
400,394
FIP icon
65
FTAI Infrastructure
FIP
$447M
$134K 0.06%
34,553
-488,361
-93% -$1.71M
AXDX
66
DELISTED
Accelerate Diagnostics
AXDX
$53.4K 0.02%
13,614
PAA icon
67
Plains All American Pipeline
PAA
$17.6B
$1.56K ﹤0.01%
+38,940
New +$595K
AA icon
68
Alcoa
AA
$11.3B
-50,000
Closed -$1.45M
AMRX icon
69
Amneal Pharmaceuticals
AMRX
$6.1B
-96,672
Closed -$408K
FLR icon
70
Fluor
FLR
$6.54B
-60,000
Closed -$2.2M
HTZ icon
71
Hertz
HTZ
$527M
-225,000
Closed -$2.76M
LLY icon
72
PUT
Eli Lilly
LLY
$1.08T
-350
Closed -$588K
METCB icon
73
Ramaco Resources Class B
METCB
$423M
-30,173
Closed -$334K
METC icon
74
Ramaco Resources Class A
METC
$629M
-117,542
Closed -$1.25M
PTON icon
75
Peloton Interactive
PTON
$2.85B
-150,000
Closed -$758K

Similar funds

Tejara Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Tejara Capital held 79 positions worth $239M, up 35% from $176M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Tejara Capital deployed $47.1M of net new capital in Q4 2023, opening 15 new positions and adding to 27 existing holdings. Its largest new stake was Newmont: 231,300 shares worth $9.57M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 25% a quarter earlier, followed by Energy and Materials.

On the sell side, the largest reduction was Citigroup, an estimated $13.4M trimmed.

  • Tejara Capital's largest Q4 2023 buy was Newmont: 231,300 shares worth $9.57M.
  • Tejara Capital added most to Roivant Sciences in Q4 2023, an estimated $17.3M increase.
  • Tejara Capital's biggest Q4 2023 reduction was Citigroup, cutting an estimated $13.4M.
  • Tejara Capital fully exited Hertz in Q4 2023, selling an estimated $2.76M.
  • Tejara Capital's ten largest holdings make up 47% of its $239M portfolio in Q4 2023.
  • Tejara Capital opened 15 new positions and closed 12 in Q4 2023.
  • Tejara Capital's portfolio value rose 35% quarter-over-quarter to $239M.

Based on Tejara Capital's 13F filing for Q4 2023, filed 12 Feb 2024.